The National Agency for Food and Drug Administration and Control (NAFDAC) says it has ordered the manufacturing of Chloroquine for emergency stock for possible clinical treatment of Corona virus.

The agency’s Director-General, Professor MOJISOLA ADEYEYE, in a statement said the old antimalarial is now being repurposed for the clinical trial treatment of Corona virus.

Professor ADEYEYE said the decision follows the use of Chloroquine in other countries to treat Corona virus.

She explained further that Chloroquine was discontinued in Nigeria many years ago for use as anti-malarial because of the resistance that the parasite developed against the drug but now she has approached a manufacturer to make a batch of the drug for emergency stock.